234 related articles for article (PubMed ID: 31796374)
21. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.
Kristiansen A; Drevin L; Delahunt B; Samaratunga H; Robinson D; Franck Lissbrant I; Stattin P; Egevad L
Pathology; 2017 Dec; 49(7):715-720. PubMed ID: 29037803
[TBL] [Abstract][Full Text] [Related]
22. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.
Masic S; Cowan JE; Washington SL; Nguyen HG; Shinohara K; Cooperberg MR; Carroll PR
Eur Urol Oncol; 2018 Oct; 1(5):386-394. PubMed ID: 31158077
[TBL] [Abstract][Full Text] [Related]
23. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
24. Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study.
Ishizaki F; Hara N; Koike H; Kawaguchi M; Tadokoro A; Takizawa I; Nishiyama T; Takahashi K; Hohenfellner R
Diagn Pathol; 2012 Jun; 7():68. PubMed ID: 22697234
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.
Isbarn H; Ahyai SA; Chun FK; Budäus L; Schlomm T; Salomon G; Zacharias M; Erbersdobler A; Köllermann J; Sauter G; Huland H; Graefen M; Steuber T
Eur Urol; 2009 Feb; 55(2):394-401. PubMed ID: 18718699
[TBL] [Abstract][Full Text] [Related]
26. Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy.
Pagano MJ; Whalen MJ; Paulucci DJ; Reddy BN; Matulay JT; Rothberg M; Scarberry K; Patel T; Shapiro EY; RoyChoudhury A; McKiernan J; Benson MC; Badani KK
Prostate; 2016 Feb; 76(2):226-34. PubMed ID: 26481325
[TBL] [Abstract][Full Text] [Related]
27. Do all men with pathological Gleason score 8-10 prostate cancer have poor outcomes? Results from the SEARCH database.
Fischer S; Lin D; Simon RM; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ; Vidal AC
BJU Int; 2016 Aug; 118(2):250-7. PubMed ID: 26351095
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer.
Gupta N; Bivalacqua TJ; Han M; Gorin MA; Challacombe BJ; Partin AW; Mamawala MK
BJU Int; 2019 Aug; 124(2):268-274. PubMed ID: 30570825
[TBL] [Abstract][Full Text] [Related]
29. Determining the cut-off values of tumor diameter, degree of extraprostatic extension, and extent of surgical margin positivity with regard to biochemical recurrence of prostate cancer after radical prostatectomy.
Kir G; Arikan EA; Seneldir H; Ankarali H; Oznergiz S; Olgun ZC; Yildirim A
Ann Diagn Pathol; 2020 Feb; 44():151431. PubMed ID: 31837592
[TBL] [Abstract][Full Text] [Related]
30. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8.
Manoharan M; Bird VG; Kim SS; Civantos F; Soloway MS
BJU Int; 2003 Oct; 92(6):539-44. PubMed ID: 14511029
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI.
Chung DY; Koh DH; Goh HJ; Kim MS; Lee JS; Jang WS; Choi YD
BMC Cancer; 2018 Nov; 18(1):1057. PubMed ID: 30382916
[TBL] [Abstract][Full Text] [Related]
32. Extraprostatic Extension Is Extremely Rare for Contemporary Gleason Score 6 Prostate Cancer.
Anderson BB; Oberlin DT; Razmaria AA; Choy B; Zagaja GP; Shalhav AL; Meeks JJ; Yang XJ; Paner GP; Eggener SE
Eur Urol; 2017 Sep; 72(3):455-460. PubMed ID: 27986368
[TBL] [Abstract][Full Text] [Related]
33. Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ-confined prostate cancer.
Preisser F; Coxilha G; Heinze A; Oh S; Chun FK; Sauter G; Pompe RS; Huland H; Graefen M; Tilki D
Prostate; 2019 Dec; 79(16):1832-1836. PubMed ID: 31553506
[TBL] [Abstract][Full Text] [Related]
34. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.
Freedland SJ; Aronson WJ; Csathy GS; Kane CJ; Amling CL; Presti JC; Dorey F; Terris MK;
Urology; 2003 Apr; 61(4):742-7. PubMed ID: 12670558
[TBL] [Abstract][Full Text] [Related]
35. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy.
Patel U; Dasgupta P; Challacombe B; Cahill D; Brown C; Patel R; Kirby R
BJU Int; 2017 Jan; 119(1):82-90. PubMed ID: 27153933
[TBL] [Abstract][Full Text] [Related]
36. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease.
Badani KK; Reddy BN; Moskowitz EJ; Paulucci DJ; Beksac AT; Martini A; Whalen MJ; Skarecky DW; Huynh LM; Ahlering TE
Urol Oncol; 2018 Jun; 36(6):310.e1-310.e6. PubMed ID: 29625782
[TBL] [Abstract][Full Text] [Related]
37. Findings in 12-core transrectal ultrasound-guided prostate needle biopsy that predict more advanced cancer at prostatectomy: analysis of 388 biopsy-prostatectomy pairs.
Kryvenko ON; Diaz M; Meier FA; Ramineni M; Menon M; Gupta NS
Am J Clin Pathol; 2012 May; 137(5):739-46. PubMed ID: 22523212
[TBL] [Abstract][Full Text] [Related]
38. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
Egan AJ; Bostwick DG
Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
[TBL] [Abstract][Full Text] [Related]
39. Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer.
Zhu S; Zhao JG; Chen JR; Liu ZH; Sun GX; Wang ZP; Ni YC; Dai JD; Shen PF; Zeng H
Asian J Androl; 2020; 22(5):519-525. PubMed ID: 31710002
[TBL] [Abstract][Full Text] [Related]
40. Effect of positive surgical margins at radical prostatectomy on cancer-specific mortality in high/very high-risk prostate cancer patients with Gleason Grade Group 4-5.
Panunzio A; Sorce G; Hoeh B; Hohenhorst L; Tappero S; Nimer N; Rajwa P; Tian Z; Terrone C; Chun FKH; Briganti A; Saad F; Shariat SF; Cerruto MA; Antonelli A; Karakiewicz PI
Prostate; 2023 Feb; 83(3):268-276. PubMed ID: 36336728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
